The present invention relates to the field of infection and inflammation and, more specifically, to the field of pathogen-induced nuclear factor kappa B activation. More specifically, a novel splice variant of MyD88, (MyD88.sub.S), which has been identified encoding a protein that inhibits LPS-induced NF-.kappa.B activation. MyD88.sub.S is a target to inhibit the phenomenon of endotoxin-tolerance that occurs in sepsis.

 
Web www.patentalert.com

< Method for effecting computer implemented decision-support in the selection of the drug therapy of patients having a viral disease

< Method and apparatus for detecting DNA hybridization

> Cationic polysaccharide compositions

> Vitro assay for testing gabapentinoid activity

~ 00296